Birth control options for women

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Oral Contraception
• Implant Contraception
• Injected Contraception
• Intrauterine Devices (IUDs)...
• Spermicidal and Barrier Con...
• Natural Family Planning Met...
• Emergency Contraception
• Female Sterilization
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights First "No-Period" Birth Control Pill Approved In May 2007, the Food and Drug Administration approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progestin levonorgestrol. The active pills are taken 365 days a year with no inactive pill breaks. - 1 Comment

Sleep apnea

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Symptoms
• Causes
• Risk Factors
• Prognosis
• Diagnosis
• Lifestyle Changes
• Treatment
• Dental Devices
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sleep Apnea and Heart Attack Obstructive sleep apnea can increase the risk of heart attack by as much as 30% over the course of 5 years, suggests a study presented at the 2007 American Thoracic Society International Conference. Researchers noted that the risk of developing or dying from heart disease rises with increasing sleep apnea severity. Sleep Apnea and Diabetes

• Obstructive sleep apnea may increase the risk of developing type 2 diabetes, indicates research presented at the American Thoracic Society conference. - 1 Comment
  Read More ›

Heart failure

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Complications
• Diagnosis
• Treatment
• Medications
• Surgery and Devices
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Permanent Implantable Heart Approved In 2006, the FDA approved the first permanent artificial heart. The AbiCor is intended for patients who are not eligible for heart transplants and who are only expected to survive about a month without medical treatment. Patients who received the AbiCor have survived, on average, about 5 months. - 0 Comments

Asthma in adults

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Symptoms
• Causes
• Prognosis
• Risk Factors
• Diagnosis
• Treatment
• Quick-Relief Medications...
• Long-Term Relief Medication...
• Other Treatments
• Managing Asthma
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Warning In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Omalizumab is approved for patients who have moderate-to-severe asthma related to allergies and whose symptoms are not controlled by inhaled corticosteroids. It is given by injection in a doctor’s office every 2 - 4 weeks. - 0 Comments

Urinary incontinence

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence
• Functional Incontinence
• Risk Factors
• Diagnosis
• Prognosis
• Treatment
• Lifestyle Changes
• Other Treatments
• Behavioral Treatments
• Medications
• Surgery
• Other Procedures
• Catheters and Collection De...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sling Procedure Versus Burch Colposuspension The sling procedure is better than Burch colposuspension in treating stress incontinence but may cause more post-operative urinary complications, according to results from an important 2007 New England Journal of Medicine study. In the first large-scale clinical trial to directly compare these two types of surgery, 47% of women who underwent the sling procedure had no urinary incontinence 2 years after surgery, compared with 38% of women who received the Burch procedure. However, 63% of women who had the sling procedure (and 47% of women who underwent the Burch procedure) experienced urinary tract infections following surgery. - 0 Comments